nodes	percent_of_prediction	percent_of_DWPC	metapath
Bumetanide—PTGS2—esophageal cancer	0.28	1	CbGaD
Bumetanide—SLC22A11—Methotrexate—esophageal cancer	0.0814	0.225	CbGbCtD
Bumetanide—SLC22A7—Methotrexate—esophageal cancer	0.0776	0.214	CbGbCtD
Bumetanide—PTGS2—Cisplatin—esophageal cancer	0.0686	0.189	CbGbCtD
Bumetanide—SLCO1A2—Methotrexate—esophageal cancer	0.0544	0.15	CbGbCtD
Bumetanide—SLC22A8—Methotrexate—esophageal cancer	0.0474	0.131	CbGbCtD
Bumetanide—SLC22A6—Methotrexate—esophageal cancer	0.033	0.091	CbGbCtD
Bumetanide—Serum amylase increased—Cisplatin—esophageal cancer	0.0122	0.164	CcSEcCtD
Bumetanide—CFTR—exocrine gland—esophageal cancer	0.00683	0.0935	CbGeAlD
Bumetanide—SLC12A2—exocrine gland—esophageal cancer	0.006	0.0821	CbGeAlD
Bumetanide—Ear discomfort—Capecitabine—esophageal cancer	0.00574	0.0774	CcSEcCtD
Bumetanide—Diuresis—Cisplatin—esophageal cancer	0.00412	0.0556	CcSEcCtD
Bumetanide—CFTR—epithelium—esophageal cancer	0.00297	0.0407	CbGeAlD
Bumetanide—CFTR—bronchus—esophageal cancer	0.00292	0.0401	CbGeAlD
Bumetanide—Amylase increased—Cisplatin—esophageal cancer	0.00268	0.0362	CcSEcCtD
Bumetanide—CFTR—trachea—esophageal cancer	0.00263	0.036	CbGeAlD
Bumetanide—SLC12A2—epithelium—esophageal cancer	0.00261	0.0357	CbGeAlD
Bumetanide—Furosemide—CA1—esophageal cancer	0.0026	0.292	CrCbGaD
Bumetanide—CA7—trachea—esophageal cancer	0.00259	0.0354	CbGeAlD
Bumetanide—SLC12A2—bronchus—esophageal cancer	0.00257	0.0352	CbGeAlD
Bumetanide—SLC12A4—lung—esophageal cancer	0.0024	0.0329	CbGeAlD
Bumetanide—SLC12A2—trachea—esophageal cancer	0.00231	0.0316	CbGeAlD
Bumetanide—CFTR—digestive system—esophageal cancer	0.00226	0.0309	CbGeAlD
Bumetanide—CA7—digestive system—esophageal cancer	0.00222	0.0305	CbGeAlD
Bumetanide—SLC12A1—epithelium—esophageal cancer	0.00219	0.03	CbGeAlD
Bumetanide—Serum creatinine increased—Cisplatin—esophageal cancer	0.00208	0.028	CcSEcCtD
Bumetanide—SLC12A2—digestive system—esophageal cancer	0.00198	0.0272	CbGeAlD
Bumetanide—Furosemide—CA2—esophageal cancer	0.00197	0.221	CrCbGaD
Bumetanide—CA9—digestive system—esophageal cancer	0.00195	0.0268	CbGeAlD
Bumetanide—CFTR—lung—esophageal cancer	0.00189	0.0258	CbGeAlD
Bumetanide—SLC10A1—digestive system—esophageal cancer	0.00187	0.0257	CbGeAlD
Bumetanide—CA4—neck—esophageal cancer	0.00173	0.0237	CbGeAlD
Bumetanide—SLC22A11—digestive system—esophageal cancer	0.00171	0.0235	CbGeAlD
Bumetanide—Indapamide—CA2—esophageal cancer	0.0017	0.191	CrCbGaD
Bumetanide—CA12—trachea—esophageal cancer	0.00168	0.023	CbGeAlD
Bumetanide—SLC22A7—digestive system—esophageal cancer	0.00167	0.0229	CbGeAlD
Bumetanide—SLC12A2—lung—esophageal cancer	0.00166	0.0227	CbGeAlD
Bumetanide—SLC12A4—lymph node—esophageal cancer	0.00164	0.0225	CbGeAlD
Bumetanide—Serum creatinine increased—Capecitabine—esophageal cancer	0.00153	0.0207	CcSEcCtD
Bumetanide—Liver injury—Cisplatin—esophageal cancer	0.00152	0.0205	CcSEcCtD
Bumetanide—Encephalopathy—Capecitabine—esophageal cancer	0.00147	0.0198	CcSEcCtD
Bumetanide—CA12—digestive system—esophageal cancer	0.00145	0.0198	CbGeAlD
Bumetanide—Furosemide—ABCC2—esophageal cancer	0.00143	0.16	CrCbGaD
Bumetanide—Hyperuricaemia—Cisplatin—esophageal cancer	0.00138	0.0186	CcSEcCtD
Bumetanide—Hearing impaired—Cisplatin—esophageal cancer	0.00134	0.0181	CcSEcCtD
Bumetanide—Azotaemia—Methotrexate—esophageal cancer	0.00132	0.0178	CcSEcCtD
Bumetanide—Blood uric acid increased—Cisplatin—esophageal cancer	0.0013	0.0176	CcSEcCtD
Bumetanide—Hepatocellular injury—Cisplatin—esophageal cancer	0.00128	0.0172	CcSEcCtD
Bumetanide—CA12—lung—esophageal cancer	0.00121	0.0165	CbGeAlD
Bumetanide—SLC12A2—lymph node—esophageal cancer	0.00113	0.0155	CbGeAlD
Bumetanide—Encephalopathy—Methotrexate—esophageal cancer	0.00109	0.0147	CcSEcCtD
Bumetanide—CA5B—lung—esophageal cancer	0.00108	0.0148	CbGeAlD
Bumetanide—Polyuria—Cisplatin—esophageal cancer	0.00106	0.0142	CcSEcCtD
Bumetanide—CA4—trachea—esophageal cancer	0.00104	0.0142	CbGeAlD
Bumetanide—SLCO1A2—digestive system—esophageal cancer	0.00101	0.0139	CbGeAlD
Bumetanide—Hearing impaired—Capecitabine—esophageal cancer	0.00099	0.0133	CcSEcCtD
Bumetanide—Hyponatraemia—Cisplatin—esophageal cancer	0.000932	0.0126	CcSEcCtD
Bumetanide—CA4—digestive system—esophageal cancer	0.000895	0.0123	CbGeAlD
Bumetanide—Blood creatinine increased—Cisplatin—esophageal cancer	0.000869	0.0117	CcSEcCtD
Bumetanide—Dehydration—Cisplatin—esophageal cancer	0.000863	0.0116	CcSEcCtD
Bumetanide—SLCO1A2—lung—esophageal cancer	0.000845	0.0116	CbGeAlD
Bumetanide—Hypokalaemia—Cisplatin—esophageal cancer	0.000844	0.0114	CcSEcCtD
Bumetanide—Cramp muscle—Cisplatin—esophageal cancer	0.000836	0.0113	CcSEcCtD
Bumetanide—Pancreatitis—Cisplatin—esophageal cancer	0.000786	0.0106	CcSEcCtD
Bumetanide—Polyuria—Capecitabine—esophageal cancer	0.000779	0.0105	CcSEcCtD
Bumetanide—Fenoprofen—PTGS1—esophageal cancer	0.000776	0.0871	CrCbGaD
Bumetanide—Abdominal discomfort—Cisplatin—esophageal cancer	0.000769	0.0104	CcSEcCtD
Bumetanide—Hyperuricaemia—Methotrexate—esophageal cancer	0.000756	0.0102	CcSEcCtD
Bumetanide—CA4—lung—esophageal cancer	0.000747	0.0102	CbGeAlD
Bumetanide—CA5B—lymph node—esophageal cancer	0.000741	0.0101	CbGeAlD
Bumetanide—PTGS2—epithelium—esophageal cancer	0.00072	0.00986	CbGeAlD
Bumetanide—Blood uric acid increased—Methotrexate—esophageal cancer	0.000714	0.00963	CcSEcCtD
Bumetanide—PTGS2—bronchus—esophageal cancer	0.000709	0.00971	CbGeAlD
Bumetanide—Renal failure—Cisplatin—esophageal cancer	0.000703	0.00948	CcSEcCtD
Bumetanide—PTGS2—smooth muscle tissue—esophageal cancer	0.000694	0.0095	CbGeAlD
Bumetanide—Hyponatraemia—Capecitabine—esophageal cancer	0.000687	0.00926	CcSEcCtD
Bumetanide—Blood creatinine increased—Capecitabine—esophageal cancer	0.000641	0.00864	CcSEcCtD
Bumetanide—PTGS2—trachea—esophageal cancer	0.000637	0.00872	CbGeAlD
Bumetanide—Dehydration—Capecitabine—esophageal cancer	0.000636	0.00858	CcSEcCtD
Bumetanide—Gynaecomastia—Methotrexate—esophageal cancer	0.000628	0.00846	CcSEcCtD
Bumetanide—Hypokalaemia—Capecitabine—esophageal cancer	0.000622	0.00839	CcSEcCtD
Bumetanide—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.000616	0.0083	CcSEcCtD
Bumetanide—Polyuria—Methotrexate—esophageal cancer	0.00058	0.00782	CcSEcCtD
Bumetanide—Abdominal discomfort—Capecitabine—esophageal cancer	0.000567	0.00764	CcSEcCtD
Bumetanide—PTGS2—digestive system—esophageal cancer	0.000548	0.0075	CbGeAlD
Bumetanide—Muscle spasms—Cisplatin—esophageal cancer	0.000537	0.00724	CcSEcCtD
Bumetanide—Hyperglycaemia—Capecitabine—esophageal cancer	0.000533	0.00719	CcSEcCtD
Bumetanide—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000523	0.00705	CcSEcCtD
Bumetanide—Renal failure—Capecitabine—esophageal cancer	0.000518	0.00699	CcSEcCtD
Bumetanide—CA4—lymph node—esophageal cancer	0.000511	0.007	CbGeAlD
Bumetanide—Leukopenia—Cisplatin—esophageal cancer	0.0005	0.00674	CcSEcCtD
Bumetanide—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.000458	0.00618	CcSEcCtD
Bumetanide—PTGS2—lung—esophageal cancer	0.000458	0.00627	CbGeAlD
Bumetanide—Erythema multiforme—Capecitabine—esophageal cancer	0.000447	0.00603	CcSEcCtD
Bumetanide—Thrombocytopenia—Cisplatin—esophageal cancer	0.000447	0.00602	CcSEcCtD
Bumetanide—Fenoprofen—PTGS2—esophageal cancer	0.000444	0.0498	CrCbGaD
Bumetanide—Hyperhidrosis—Cisplatin—esophageal cancer	0.000441	0.00594	CcSEcCtD
Bumetanide—Pancreatitis—Methotrexate—esophageal cancer	0.000431	0.00582	CcSEcCtD
Bumetanide—Hypotension—Cisplatin—esophageal cancer	0.000426	0.00575	CcSEcCtD
Bumetanide—Abdominal discomfort—Methotrexate—esophageal cancer	0.000422	0.00569	CcSEcCtD
Bumetanide—Muscle spasms—Capecitabine—esophageal cancer	0.000396	0.00534	CcSEcCtD
Bumetanide—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000389	0.00525	CcSEcCtD
Bumetanide—Renal failure—Methotrexate—esophageal cancer	0.000386	0.0052	CcSEcCtD
Bumetanide—Sweating—Methotrexate—esophageal cancer	0.000376	0.00507	CcSEcCtD
Bumetanide—Vertigo—Capecitabine—esophageal cancer	0.00037	0.00499	CcSEcCtD
Bumetanide—Leukopenia—Capecitabine—esophageal cancer	0.000369	0.00497	CcSEcCtD
Bumetanide—Chest pain—Capecitabine—esophageal cancer	0.000351	0.00473	CcSEcCtD
Bumetanide—Arthralgia—Capecitabine—esophageal cancer	0.000351	0.00473	CcSEcCtD
Bumetanide—Dry mouth—Capecitabine—esophageal cancer	0.000343	0.00462	CcSEcCtD
Bumetanide—Erythema multiforme—Methotrexate—esophageal cancer	0.000333	0.00449	CcSEcCtD
Bumetanide—Thrombocytopenia—Capecitabine—esophageal cancer	0.000329	0.00444	CcSEcCtD
Bumetanide—Asthenia—Cisplatin—esophageal cancer	0.000327	0.00441	CcSEcCtD
Bumetanide—Hyperhidrosis—Capecitabine—esophageal cancer	0.000325	0.00438	CcSEcCtD
Bumetanide—Hypotension—Capecitabine—esophageal cancer	0.000314	0.00424	CcSEcCtD
Bumetanide—PTGS2—lymph node—esophageal cancer	0.000313	0.00429	CbGeAlD
Bumetanide—Diarrhoea—Cisplatin—esophageal cancer	0.000312	0.00421	CcSEcCtD
Bumetanide—Vomiting—Cisplatin—esophageal cancer	0.00029	0.00391	CcSEcCtD
Bumetanide—Fatigue—Capecitabine—esophageal cancer	0.00029	0.00391	CcSEcCtD
Bumetanide—Rash—Cisplatin—esophageal cancer	0.000288	0.00388	CcSEcCtD
Bumetanide—Dermatitis—Cisplatin—esophageal cancer	0.000287	0.00387	CcSEcCtD
Bumetanide—Vertigo—Methotrexate—esophageal cancer	0.000275	0.00371	CcSEcCtD
Bumetanide—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000275	0.00371	CcSEcCtD
Bumetanide—Leukopenia—Methotrexate—esophageal cancer	0.000274	0.0037	CcSEcCtD
Bumetanide—Nausea—Cisplatin—esophageal cancer	0.000271	0.00365	CcSEcCtD
Bumetanide—Urticaria—Capecitabine—esophageal cancer	0.000267	0.0036	CcSEcCtD
Bumetanide—Abdominal pain—Capecitabine—esophageal cancer	0.000266	0.00358	CcSEcCtD
Bumetanide—Chest pain—Methotrexate—esophageal cancer	0.000261	0.00352	CcSEcCtD
Bumetanide—Arthralgia—Methotrexate—esophageal cancer	0.000261	0.00352	CcSEcCtD
Bumetanide—Thrombocytopenia—Methotrexate—esophageal cancer	0.000245	0.0033	CcSEcCtD
Bumetanide—Hyperhidrosis—Methotrexate—esophageal cancer	0.000242	0.00326	CcSEcCtD
Bumetanide—Asthenia—Capecitabine—esophageal cancer	0.000241	0.00325	CcSEcCtD
Bumetanide—Pruritus—Capecitabine—esophageal cancer	0.000238	0.00321	CcSEcCtD
Bumetanide—Hypotension—Methotrexate—esophageal cancer	0.000234	0.00315	CcSEcCtD
Bumetanide—Diarrhoea—Capecitabine—esophageal cancer	0.00023	0.0031	CcSEcCtD
Bumetanide—Dizziness—Capecitabine—esophageal cancer	0.000222	0.003	CcSEcCtD
Bumetanide—Fatigue—Methotrexate—esophageal cancer	0.000216	0.00291	CcSEcCtD
Bumetanide—Vomiting—Capecitabine—esophageal cancer	0.000214	0.00288	CcSEcCtD
Bumetanide—Rash—Capecitabine—esophageal cancer	0.000212	0.00286	CcSEcCtD
Bumetanide—Dermatitis—Capecitabine—esophageal cancer	0.000212	0.00286	CcSEcCtD
Bumetanide—Headache—Capecitabine—esophageal cancer	0.000211	0.00284	CcSEcCtD
Bumetanide—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000205	0.00276	CcSEcCtD
Bumetanide—Nausea—Capecitabine—esophageal cancer	0.0002	0.00269	CcSEcCtD
Bumetanide—Urticaria—Methotrexate—esophageal cancer	0.000199	0.00268	CcSEcCtD
Bumetanide—Abdominal pain—Methotrexate—esophageal cancer	0.000198	0.00267	CcSEcCtD
Bumetanide—Asthenia—Methotrexate—esophageal cancer	0.00018	0.00242	CcSEcCtD
Bumetanide—Pruritus—Methotrexate—esophageal cancer	0.000177	0.00239	CcSEcCtD
Bumetanide—Diarrhoea—Methotrexate—esophageal cancer	0.000171	0.00231	CcSEcCtD
Bumetanide—Dizziness—Methotrexate—esophageal cancer	0.000165	0.00223	CcSEcCtD
Bumetanide—Vomiting—Methotrexate—esophageal cancer	0.000159	0.00215	CcSEcCtD
Bumetanide—Rash—Methotrexate—esophageal cancer	0.000158	0.00213	CcSEcCtD
Bumetanide—Dermatitis—Methotrexate—esophageal cancer	0.000158	0.00213	CcSEcCtD
Bumetanide—Headache—Methotrexate—esophageal cancer	0.000157	0.00211	CcSEcCtD
Bumetanide—Nausea—Methotrexate—esophageal cancer	0.000149	0.002	CcSEcCtD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—esophageal cancer	5.58e-05	0.000277	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—SMAD4—esophageal cancer	5.58e-05	0.000277	CbGpPWpGaD
Bumetanide—CA9—Metabolism—ALOX15—esophageal cancer	5.54e-05	0.000275	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—CYP19A1—esophageal cancer	5.51e-05	0.000274	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	5.51e-05	0.000274	CbGpPWpGaD
Bumetanide—CA7—Metabolism—CYP1B1—esophageal cancer	5.47e-05	0.000272	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—CYP1B1—esophageal cancer	5.47e-05	0.000272	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—RB1—esophageal cancer	5.46e-05	0.000271	CbGpPWpGaD
Bumetanide—SLC22A11—Transmembrane transport of small molecules—ABCB1—esophageal cancer	5.41e-05	0.000269	CbGpPWpGaD
Bumetanide—CA9—Cellular responses to stress—CDKN1A—esophageal cancer	5.34e-05	0.000265	CbGpPWpGaD
Bumetanide—CA4—Metabolism—ALDH2—esophageal cancer	5.33e-05	0.000265	CbGpPWpGaD
Bumetanide—PTGS2—C-MYB transcription factor network—CCND1—esophageal cancer	5.32e-05	0.000264	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—GSTT1—esophageal cancer	5.32e-05	0.000264	CbGpPWpGaD
Bumetanide—CA9—Metabolism—GSTO1—esophageal cancer	5.29e-05	0.000263	CbGpPWpGaD
Bumetanide—CA9—Metabolism—TPI1—esophageal cancer	5.29e-05	0.000263	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—BAX—esophageal cancer	5.27e-05	0.000262	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—CYP2A6—esophageal cancer	5.26e-05	0.000261	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—SLC10A2—esophageal cancer	5.24e-05	0.00026	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CA1—esophageal cancer	5.24e-05	0.00026	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	5.24e-05	0.00026	CbGpPWpGaD
Bumetanide—CA14—Metabolism—HMOX1—esophageal cancer	5.16e-05	0.000256	CbGpPWpGaD
Bumetanide—PTGS2—C-MYB transcription factor network—CDKN1A—esophageal cancer	5.15e-05	0.000256	CbGpPWpGaD
Bumetanide—CA7—Metabolism—CYP19A1—esophageal cancer	5.14e-05	0.000256	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—CYP19A1—esophageal cancer	5.14e-05	0.000256	CbGpPWpGaD
Bumetanide—SLC22A7—Transmembrane transport of small molecules—HMOX1—esophageal cancer	5.12e-05	0.000254	CbGpPWpGaD
Bumetanide—CA9—Cellular responses to stress—EP300—esophageal cancer	5.08e-05	0.000253	CbGpPWpGaD
Bumetanide—CA4—Metabolism—GSTT1—esophageal cancer	5.07e-05	0.000252	CbGpPWpGaD
Bumetanide—CA12—Metabolism—CYP1B1—esophageal cancer	5.07e-05	0.000252	CbGpPWpGaD
Bumetanide—CA9—Metabolism—ALDOB—esophageal cancer	5.07e-05	0.000252	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—HMOX1—esophageal cancer	5.03e-05	0.00025	CbGpPWpGaD
Bumetanide—CA4—Metabolism—CYP2A6—esophageal cancer	5.02e-05	0.000249	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—ENO1—esophageal cancer	4.98e-05	0.000248	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—PTGS1—esophageal cancer	4.98e-05	0.000248	CbGpPWpGaD
Bumetanide—CA14—Metabolism—ABCB1—esophageal cancer	4.95e-05	0.000246	CbGpPWpGaD
Bumetanide—SLC22A7—Transmembrane transport of small molecules—ABCB1—esophageal cancer	4.91e-05	0.000244	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—PSME1—esophageal cancer	4.91e-05	0.000244	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—PSME2—esophageal cancer	4.91e-05	0.000244	CbGpPWpGaD
Bumetanide—PTGS2—C-MYB transcription factor network—EP300—esophageal cancer	4.9e-05	0.000243	CbGpPWpGaD
Bumetanide—CA9—Metabolism—GAPDH—esophageal cancer	4.88e-05	0.000243	CbGpPWpGaD
Bumetanide—CA9—Metabolism—CRABP1—esophageal cancer	4.84e-05	0.00024	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—ABCB1—esophageal cancer	4.83e-05	0.00024	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	4.8e-05	0.000238	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CA2—esophageal cancer	4.79e-05	0.000238	CbGpPWpGaD
Bumetanide—CA12—Metabolism—CYP19A1—esophageal cancer	4.77e-05	0.000237	CbGpPWpGaD
Bumetanide—CA4—Metabolism—ENO1—esophageal cancer	4.75e-05	0.000236	CbGpPWpGaD
Bumetanide—CA4—Metabolism—PTGS1—esophageal cancer	4.75e-05	0.000236	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—HMOX1—esophageal cancer	4.69e-05	0.000233	CbGpPWpGaD
Bumetanide—CA7—Metabolism—HMOX1—esophageal cancer	4.69e-05	0.000233	CbGpPWpGaD
Bumetanide—CA4—Metabolism—PSME2—esophageal cancer	4.68e-05	0.000233	CbGpPWpGaD
Bumetanide—CA4—Metabolism—PSME1—esophageal cancer	4.68e-05	0.000233	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	4.68e-05	0.000233	CbGpPWpGaD
Bumetanide—CA9—Metabolism—GNG7—esophageal cancer	4.6e-05	0.000229	CbGpPWpGaD
Bumetanide—CA7—Metabolism—ABCB1—esophageal cancer	4.51e-05	0.000224	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—ABCB1—esophageal cancer	4.51e-05	0.000224	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—ADH7—esophageal cancer	4.45e-05	0.000221	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PLCE1—esophageal cancer	4.45e-05	0.000221	CbGpPWpGaD
Bumetanide—PTGS2—Disease—SLC52A3—esophageal cancer	4.44e-05	0.000221	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	4.4e-05	0.000219	CbGpPWpGaD
Bumetanide—CA12—Metabolism—HMOX1—esophageal cancer	4.35e-05	0.000216	CbGpPWpGaD
Bumetanide—CA9—Metabolism—ALDH2—esophageal cancer	4.31e-05	0.000214	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—HMOX1—esophageal cancer	4.3e-05	0.000214	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	4.29e-05	0.000213	CbGpPWpGaD
Bumetanide—PTGS2—C-MYB transcription factor network—MYC—esophageal cancer	4.27e-05	0.000212	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—CYP1B1—esophageal cancer	4.24e-05	0.000211	CbGpPWpGaD
Bumetanide—PTGS2—Disease—KMT2D—esophageal cancer	4.24e-05	0.000211	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	4.19e-05	0.000208	CbGpPWpGaD
Bumetanide—CA12—Metabolism—ABCB1—esophageal cancer	4.17e-05	0.000207	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—ABCB1—esophageal cancer	4.13e-05	0.000205	CbGpPWpGaD
Bumetanide—CA9—Metabolism—GSTT1—esophageal cancer	4.1e-05	0.000204	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—CCND1—esophageal cancer	4.05e-05	0.000201	CbGpPWpGaD
Bumetanide—CA9—Metabolism—CYP2A6—esophageal cancer	4.05e-05	0.000201	CbGpPWpGaD
Bumetanide—CA4—Metabolism—CYP1B1—esophageal cancer	4.04e-05	0.000201	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—CYP19A1—esophageal cancer	3.98e-05	0.000198	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—ADH1B—esophageal cancer	3.9e-05	0.000194	CbGpPWpGaD
Bumetanide—CA9—Metabolism—ENO1—esophageal cancer	3.84e-05	0.000191	CbGpPWpGaD
Bumetanide—CA9—Metabolism—PTGS1—esophageal cancer	3.84e-05	0.000191	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	3.82e-05	0.00019	CbGpPWpGaD
Bumetanide—CA4—Metabolism—CYP19A1—esophageal cancer	3.8e-05	0.000189	CbGpPWpGaD
Bumetanide—CA9—Metabolism—PSME1—esophageal cancer	3.79e-05	0.000188	CbGpPWpGaD
Bumetanide—CA9—Metabolism—PSME2—esophageal cancer	3.79e-05	0.000188	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	3.74e-05	0.000186	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—TYMP—esophageal cancer	3.73e-05	0.000185	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	3.73e-05	0.000185	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—SLC52A3—esophageal cancer	3.72e-05	0.000185	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—BLVRB—esophageal cancer	3.72e-05	0.000185	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	3.67e-05	0.000182	CbGpPWpGaD
Bumetanide—CA9—Cellular responses to stress—TP53—esophageal cancer	3.64e-05	0.000181	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—HMOX1—esophageal cancer	3.64e-05	0.000181	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CYP26A1—esophageal cancer	3.63e-05	0.00018	CbGpPWpGaD
Bumetanide—SLC22A11—Transmembrane transport of small molecules—CREBBP—esophageal cancer	3.62e-05	0.00018	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—HMOX1—esophageal cancer	3.59e-05	0.000178	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	3.57e-05	0.000177	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—ALOX15—esophageal cancer	3.54e-05	0.000176	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—ABCB1—esophageal cancer	3.49e-05	0.000173	CbGpPWpGaD
Bumetanide—CA4—Metabolism—HMOX1—esophageal cancer	3.47e-05	0.000172	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—ABCB1—esophageal cancer	3.45e-05	0.000171	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—GSTO1—esophageal cancer	3.37e-05	0.000168	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—TPI1—esophageal cancer	3.37e-05	0.000168	CbGpPWpGaD
Bumetanide—CA4—Metabolism—ABCB1—esophageal cancer	3.33e-05	0.000165	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	3.33e-05	0.000165	CbGpPWpGaD
Bumetanide—CA14—Metabolism—CREBBP—esophageal cancer	3.31e-05	0.000165	CbGpPWpGaD
Bumetanide—PTGS2—Disease—FKBP1A—esophageal cancer	3.29e-05	0.000163	CbGpPWpGaD
Bumetanide—SLC22A7—Transmembrane transport of small molecules—CREBBP—esophageal cancer	3.28e-05	0.000163	CbGpPWpGaD
Bumetanide—CA9—Metabolism—CYP1B1—esophageal cancer	3.27e-05	0.000162	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—MYC—esophageal cancer	3.25e-05	0.000162	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—ALDOB—esophageal cancer	3.24e-05	0.000161	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—CREBBP—esophageal cancer	3.23e-05	0.00016	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	3.21e-05	0.00016	CbGpPWpGaD
Bumetanide—PTGS2—Disease—DOCK2—esophageal cancer	3.21e-05	0.00016	CbGpPWpGaD
Bumetanide—PTGS2—Disease—WIF1—esophageal cancer	3.21e-05	0.00016	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—EGFR—esophageal cancer	3.18e-05	0.000158	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CA1—esophageal cancer	3.16e-05	0.000157	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—SLC10A2—esophageal cancer	3.16e-05	0.000157	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	3.12e-05	0.000155	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—GAPDH—esophageal cancer	3.11e-05	0.000155	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CRABP1—esophageal cancer	3.09e-05	0.000153	CbGpPWpGaD
Bumetanide—CA9—Metabolism—CYP19A1—esophageal cancer	3.07e-05	0.000153	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—CREBBP—esophageal cancer	3.01e-05	0.00015	CbGpPWpGaD
Bumetanide—CA7—Metabolism—CREBBP—esophageal cancer	3.01e-05	0.00015	CbGpPWpGaD
Bumetanide—CA14—Metabolism—NOS3—esophageal cancer	2.96e-05	0.000147	CbGpPWpGaD
Bumetanide—PTGS2—Disease—CSNK1A1—esophageal cancer	2.96e-05	0.000147	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—GNG7—esophageal cancer	2.94e-05	0.000146	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CA2—esophageal cancer	2.89e-05	0.000144	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—NOS3—esophageal cancer	2.89e-05	0.000144	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	2.83e-05	0.000141	CbGpPWpGaD
Bumetanide—CA9—Metabolism—HMOX1—esophageal cancer	2.8e-05	0.000139	CbGpPWpGaD
Bumetanide—CA12—Metabolism—CREBBP—esophageal cancer	2.79e-05	0.000139	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.76e-05	0.000137	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	2.76e-05	0.000137	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—ALDH2—esophageal cancer	2.75e-05	0.000137	CbGpPWpGaD
Bumetanide—CA14—Metabolism—PTGS2—esophageal cancer	2.71e-05	0.000135	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—NOS3—esophageal cancer	2.7e-05	0.000134	CbGpPWpGaD
Bumetanide—CA7—Metabolism—NOS3—esophageal cancer	2.7e-05	0.000134	CbGpPWpGaD
Bumetanide—CA9—Metabolism—ABCB1—esophageal cancer	2.69e-05	0.000134	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ADH7—esophageal cancer	2.69e-05	0.000134	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PLCE1—esophageal cancer	2.69e-05	0.000134	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—TP53—esophageal cancer	2.67e-05	0.000133	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	2.67e-05	0.000133	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	2.66e-05	0.000132	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—PTGS2—esophageal cancer	2.64e-05	0.000131	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.64e-05	0.000131	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—GSTT1—esophageal cancer	2.62e-05	0.00013	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CYP2A6—esophageal cancer	2.59e-05	0.000129	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.58e-05	0.000128	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	2.54e-05	0.000126	CbGpPWpGaD
Bumetanide—CA12—Metabolism—NOS3—esophageal cancer	2.5e-05	0.000124	CbGpPWpGaD
Bumetanide—PTGS2—Disease—ELMO1—esophageal cancer	2.49e-05	0.000124	CbGpPWpGaD
Bumetanide—CA7—Metabolism—PTGS2—esophageal cancer	2.47e-05	0.000123	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—PTGS2—esophageal cancer	2.47e-05	0.000123	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—ENO1—esophageal cancer	2.45e-05	0.000122	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PTGS1—esophageal cancer	2.45e-05	0.000122	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.45e-05	0.000122	CbGpPWpGaD
Bumetanide—PTGS2—Disease—TPI1—esophageal cancer	2.43e-05	0.000121	CbGpPWpGaD
Bumetanide—PTGS2—Disease—GSTO1—esophageal cancer	2.43e-05	0.000121	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PSME2—esophageal cancer	2.42e-05	0.00012	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PSME1—esophageal cancer	2.42e-05	0.00012	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ADH1B—esophageal cancer	2.36e-05	0.000117	CbGpPWpGaD
Bumetanide—PTGS2—Disease—ALDOB—esophageal cancer	2.33e-05	0.000116	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—CREBBP—esophageal cancer	2.33e-05	0.000116	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.3e-05	0.000114	CbGpPWpGaD
Bumetanide—CA12—Metabolism—PTGS2—esophageal cancer	2.28e-05	0.000114	CbGpPWpGaD
Bumetanide—CA14—Metabolism—EP300—esophageal cancer	2.25e-05	0.000112	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—TYMP—esophageal cancer	2.25e-05	0.000112	CbGpPWpGaD
Bumetanide—PTGS2—Disease—GAPDH—esophageal cancer	2.25e-05	0.000112	CbGpPWpGaD
Bumetanide—PTGS2—Disease—HIST1H2BM—esophageal cancer	2.25e-05	0.000112	CbGpPWpGaD
Bumetanide—CA4—Metabolism—CREBBP—esophageal cancer	2.22e-05	0.000111	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	2.21e-05	0.00011	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—EP300—esophageal cancer	2.2e-05	0.000109	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CYP26A1—esophageal cancer	2.19e-05	0.000109	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	2.16e-05	0.000108	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ALOX15—esophageal cancer	2.14e-05	0.000106	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.11e-05	0.000105	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—NOS3—esophageal cancer	2.09e-05	0.000104	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CYP1B1—esophageal cancer	2.09e-05	0.000104	CbGpPWpGaD
Bumetanide—CA7—Metabolism—EP300—esophageal cancer	2.05e-05	0.000102	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—EP300—esophageal cancer	2.05e-05	0.000102	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—GSTO1—esophageal cancer	2.04e-05	0.000101	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—TPI1—esophageal cancer	2.04e-05	0.000101	CbGpPWpGaD
Bumetanide—CA4—Metabolism—NOS3—esophageal cancer	1.99e-05	9.9e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—XIAP—esophageal cancer	1.98e-05	9.86e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CYP19A1—esophageal cancer	1.96e-05	9.74e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ALDOB—esophageal cancer	1.95e-05	9.71e-05	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—PTGS2—esophageal cancer	1.91e-05	9.49e-05	CbGpPWpGaD
Bumetanide—CA12—Metabolism—EP300—esophageal cancer	1.9e-05	9.44e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—GAPDH—esophageal cancer	1.88e-05	9.35e-05	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	1.88e-05	9.33e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CRABP1—esophageal cancer	1.86e-05	9.26e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—B2M—esophageal cancer	1.84e-05	9.17e-05	CbGpPWpGaD
Bumetanide—CA4—Metabolism—PTGS2—esophageal cancer	1.82e-05	9.06e-05	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	1.82e-05	9.03e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—CREBBP—esophageal cancer	1.8e-05	8.94e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—HMOX1—esophageal cancer	1.79e-05	8.89e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—GNG7—esophageal cancer	1.77e-05	8.81e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—ENO1—esophageal cancer	1.77e-05	8.79e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.75e-05	8.72e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—PSME2—esophageal cancer	1.74e-05	8.66e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—PSME1—esophageal cancer	1.74e-05	8.66e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—ABCB1—esophageal cancer	1.72e-05	8.53e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—CALR—esophageal cancer	1.67e-05	8.31e-05	CbGpPWpGaD
Bumetanide—CA14—Metabolism—PIK3CA—esophageal cancer	1.67e-05	8.29e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ALDH2—esophageal cancer	1.66e-05	8.26e-05	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—PIK3CA—esophageal cancer	1.63e-05	8.08e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—FBXW7—esophageal cancer	1.62e-05	8.04e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—NOS3—esophageal cancer	1.61e-05	8e-05	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—EP300—esophageal cancer	1.59e-05	7.89e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—GSTT1—esophageal cancer	1.58e-05	7.85e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CYP2A6—esophageal cancer	1.56e-05	7.76e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.56e-05	7.73e-05	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—PIK3CA—esophageal cancer	1.52e-05	7.54e-05	CbGpPWpGaD
Bumetanide—CA7—Metabolism—PIK3CA—esophageal cancer	1.52e-05	7.54e-05	CbGpPWpGaD
Bumetanide—CA4—Metabolism—EP300—esophageal cancer	1.52e-05	7.53e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ENO1—esophageal cancer	1.48e-05	7.36e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PTGS1—esophageal cancer	1.48e-05	7.36e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—PTGS2—esophageal cancer	1.47e-05	7.32e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PSME2—esophageal cancer	1.46e-05	7.25e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PSME1—esophageal cancer	1.46e-05	7.25e-05	CbGpPWpGaD
Bumetanide—CA12—Metabolism—PIK3CA—esophageal cancer	1.41e-05	6.99e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—TGFBR2—esophageal cancer	1.31e-05	6.5e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.3e-05	6.45e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CYP1B1—esophageal cancer	1.26e-05	6.26e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—SMAD4—esophageal cancer	1.24e-05	6.15e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—EP300—esophageal cancer	1.22e-05	6.09e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CYP19A1—esophageal cancer	1.18e-05	5.88e-05	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—PIK3CA—esophageal cancer	1.18e-05	5.84e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CREBBP—esophageal cancer	1.15e-05	5.7e-05	CbGpPWpGaD
Bumetanide—CA4—Metabolism—PIK3CA—esophageal cancer	1.12e-05	5.57e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—HMOX1—esophageal cancer	1.08e-05	5.37e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.06e-05	5.27e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ABCB1—esophageal cancer	1.04e-05	5.15e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—NOS3—esophageal cancer	1.03e-05	5.11e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—HIF1A—esophageal cancer	1.01e-05	5.04e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PTGS2—esophageal cancer	9.4e-06	4.67e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—NOS2—esophageal cancer	9.22e-06	4.58e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—NOTCH1—esophageal cancer	9.13e-06	4.54e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—PIK3CA—esophageal cancer	9.06e-06	4.5e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—CREBBP—esophageal cancer	8.27e-06	4.11e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	7.84e-06	3.9e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—EP300—esophageal cancer	7.82e-06	3.88e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—NOS3—esophageal cancer	7.41e-06	3.68e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CREBBP—esophageal cancer	6.93e-06	3.44e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—ERBB2—esophageal cancer	6.93e-06	3.44e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—NOS3—esophageal cancer	6.2e-06	3.08e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—CDKN1A—esophageal cancer	5.92e-06	2.94e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PIK3CA—esophageal cancer	5.78e-06	2.87e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—EP300—esophageal cancer	5.64e-06	2.8e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—MYC—esophageal cancer	4.91e-06	2.44e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—EGFR—esophageal cancer	4.8e-06	2.39e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—EP300—esophageal cancer	4.72e-06	2.35e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—PIK3CA—esophageal cancer	4.17e-06	2.07e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PIK3CA—esophageal cancer	3.49e-06	1.74e-05	CbGpPWpGaD
